Clinical Trial Update: Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update reporting results for pamiparib (BGB-290) in adults with advanced solid tumors, including advanced high-grade ovarian cancer and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Pamiparib (pamiparib)

Snippet

Sponsor: BeiGene | Conditions: Advanced High-grade Ovarian Cancer, Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-02-22